• Je něco špatně v tomto záznamu ?

Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets

K. Dvorácková, M. Rabisková, R. Masteiková, J. Muselík, K. Krejcová,

. 2009 ; 35 (8) : 930-40.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026050

The purpose of this experimental work was the development of hydrophilic-lipophilic matrix tablets for controlled release of slightly soluble drug represented here by diclofenac sodium (DS). Drug dissolution profile optimization provided by soluble filler was studied. Matrix tablets were based on cetyl alcohol as the lipophilic carrier, povidone as the gel-forming agent, and common soluble filler, that is lactose or sucrose of different particle size. Physical properties of tablets prepared by melt granulation and drug release in a phosphate buffer of pH 6.8 were evaluated. In vitro studies showed that used filler type, filler to povidone ratio and sucrose particle size influenced the drug release rate. DS dissolution profile could be changed within a wide range from about 50% per 24 hours to almost 100% in 10 hours. The release constant values confirmed that DS was released from matrices by the diffusion and anomalous transport. The influence of sucrose particle size on the drug release rate was observed. As the particle size decreased, the drug release increased significantly and its dissolution profile became more uniform. Soluble fillers participated in the pore-forming process according to their solubility and particle size. Formulations containing 100 mg of the drug, 80 mg of cetyl alcohol, 40 mg of povidone, and 80 mg of either lactose or sucrose (particle size 250-125 microm) were considered optimal for 24-hour lasting dissolution of DS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026050
003      
CZ-PrNML
005      
20121207095005.0
007      
ta
008      
120817s2009 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1080/03639040802710243 $2 doi
035    __
$a (PubMed)19274510
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Dvorácková, Katerina $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
245    10
$a Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets / $c K. Dvorácková, M. Rabisková, R. Masteiková, J. Muselík, K. Krejcová,
520    9_
$a The purpose of this experimental work was the development of hydrophilic-lipophilic matrix tablets for controlled release of slightly soluble drug represented here by diclofenac sodium (DS). Drug dissolution profile optimization provided by soluble filler was studied. Matrix tablets were based on cetyl alcohol as the lipophilic carrier, povidone as the gel-forming agent, and common soluble filler, that is lactose or sucrose of different particle size. Physical properties of tablets prepared by melt granulation and drug release in a phosphate buffer of pH 6.8 were evaluated. In vitro studies showed that used filler type, filler to povidone ratio and sucrose particle size influenced the drug release rate. DS dissolution profile could be changed within a wide range from about 50% per 24 hours to almost 100% in 10 hours. The release constant values confirmed that DS was released from matrices by the diffusion and anomalous transport. The influence of sucrose particle size on the drug release rate was observed. As the particle size decreased, the drug release increased significantly and its dissolution profile became more uniform. Soluble fillers participated in the pore-forming process according to their solubility and particle size. Formulations containing 100 mg of the drug, 80 mg of cetyl alcohol, 40 mg of povidone, and 80 mg of either lactose or sucrose (particle size 250-125 microm) were considered optimal for 24-hour lasting dissolution of DS.
650    _2
$a antiflogistika nesteroidní $x aplikace a dávkování $x chemie $7 D000894
650    _2
$a léky s prodlouženým účinkem $7 D003692
650    _2
$a diklofenak $x aplikace a dávkování $x chemie $7 D004008
650    _2
$a nosiče léků $x chemie $7 D004337
650    _2
$a pomocné látky $x chemie $7 D005079
650    _2
$a mastné alkoholy $x chemie $7 D005233
650    _2
$a laktosa $x chemie $7 D007785
650    _2
$a velikost částic $7 D010316
650    _2
$a povidon $x chemie $7 D011205
650    _2
$a rozpustnost $7 D012995
650    _2
$a sacharosa $x chemie $7 D013395
650    _2
$a tablety $7 D013607
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rabisková, Miloslava
700    1_
$a Masteiková, Ruta
700    1_
$a Muselík, Jan
700    1_
$a Krejcová, Katerina
773    0_
$w MED00001439 $t Drug development and industrial pharmacy $x 1520-5762 $g Roč. 35, č. 8 (2009), s. 930-40
856    41
$u https://pubmed.ncbi.nlm.nih.gov/19274510 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121207095039 $b ABA008
999    __
$a ok $b bmc $g 948092 $s 783396
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2009 $b 35 $c 8 $d 930-40 $i 1520-5762 $m Drug development and industrial pharmacy $n Drug Dev Ind Pharm $x MED00001439
LZP    __
$a Pubmed-20120817/10/03

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...